ADC Therapeutics SA Share-based Payment Arrangement, Amount Capitalized
ADC Therapeutics SA (ADCT) reported Share-based Payment Arrangement, Amount Capitalized of $81.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-13
- ADC Therapeutics SA share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $81.00K.
- ADC Therapeutics SA share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $64.00K.
- ADC Therapeutics SA share-based payment arrangement, amount capitalized for the quarter ending 2025-03-31 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month |
|---|---|---|
| 2026-06-30 | $81.00K 10-Q · filed 2026-08-13 | $145.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $64.00K 10-Q · filed 2026-05-04 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |